Rui Ning Chia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rui Ning Chia has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Chenjie Xu
City University of Hong Kong
2 shared publications Chao-Mao Hsieh
School of Chemical and Biomedical Engineering, Nanyang Technological University, 70 Nanyang Drive, Singapore 637457, Singapore
1 shared publicationChristian Wiraja
School of Chemical and Biomedical Engineering, Nanyang Technological University, Nanyang Technological University, 62 Nanyang Drive, 637459, Singapore 637459, Singapore
1 shared publication- Daniel Chin Shiuan Lio
School of Chemical and Biomedical Engineering, Nanyang Technological University, Nanyang Technological University, 62 Nanyang Drive, 637459, Singapore 637459, Singapore
1 shared publication - David Laurence Becker
Lee Kong Chian School of Medicine, Nanyang Technological University
1 shared publication Hao Chang
School of Chemical and Biomedical Engineering, Nanyang Technological University, 70 Nanyang Drive, Singapore 637457, Singapore
1 shared publication
Latest Publications
- Open Access
- 29 May 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (22) , eaaz6919
Temporal pressure enhanced topical drug delivery through micropore formation
Transdermal drug delivery uses chemical, physical, or biochemical enhancers to cross the skin barrier. However, existing platforms require high doses of chemical enhancers or sophisticated equipment, use fragile biomolecules, or are limited to a certain type of drug. Here, we report an innovative methodology based on temporal pressure to enhance the penetration of all kinds of drugs, from small molecules to proteins and nanoparticles (up to 500 nm). The creation of micropores (~3 μm2) on the epidermal layer through a temporal pressure treatment results in the elevated expression of gap junctions, and reduced expression of occludin tight junctions. A 1 min treatment of 0.28-MPa allows nanoparticles (up to 500 nm) and macromolecules (up to 20 kDa) to reach a depth of 430-μm into the dermal layer. Using, as an example, the delivery of insulin through topical application after the pressure treatment yields up to 80% drop in blood glucose in diabetic mice.
- 29 May 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (22) , eaaz6919
Open AccessTemporal pressure enhanced topical drug delivery through micropore formation
Transdermal drug delivery uses chemical, physical, or biochemical enhancers to cross the skin barrier. However, existing platforms require high doses of chemical enhancers or sophisticated equipment, use fragile biomolecules, or are limited to a certain type of drug. Here, we report an innovative methodology based on temporal pressure to enhance the penetration of all kinds of drugs, from small molecules to proteins and nanoparticles (up to 500 nm). The creation of micropores (~3 μm2) on the epidermal layer through a temporal pressure treatment results in the elevated expression of gap junctions, and reduced expression of occludin tight junctions. A 1 min treatment of 0.28-MPa allows nanoparticles (up to 500 nm) and macromolecules (up to 20 kDa) to reach a depth of 430-μm into the dermal layer. Using, as an example, the delivery of insulin through topical application after the pressure treatment yields up to 80% drop in blood glucose in diabetic mice.
- 19 May 2020
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 5 (6) , 1777-1785
Surface Enhanced Raman Spectroscopy Based Biosensor with a Microneedle Array for Minimally Invasive In Vivo Glucose Measurements
To monitor blood glucose level reliably, diabetic patients usually have to undergo frequent fingerstick tests to draw out fresh blood which is painful and inconvenient with potential risk of cross contamination especially when the lancet is reused or not properly steri-lized. This work reports a novel SERS (surface enhanced Raman spectroscopy) sensor for the in situ intradermal detection of glucose based on a low-cost PMMA MN array. After incorporating 1-decanethiol (1-DT) onto the silver-coated array surface, the sensor was calibrated in the range of 0 to 20 mM in skin phantoms then tested for the in vivo quantification of glucose in a mouse model of STZ- induced type Ⅰ diabetes. The results showed that the functional polymethyl methacrylate microneedle (F-PMMA MN) array was able to directly measure glucose in the ISF in a few mins and retain its structural integrity without swelling hydrated. The Clarke error grid analysis of measured data indicated that 93% of the data points lie in zones A and B. Moreover, the MN array exhibited minimal inva-siveness to the skin as the skin recovered well without any noticeable adverse reaction in 10 mins after measurements. With further improvement and proper validation, this polymeric MN array based SERS biosensor has the potential to be used in painless glucose monitoring of diabetic patients in the future.
- 19 May 2020
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 5 (6) , 1777-1785
Surface Enhanced Raman Spectroscopy Based Biosensor with a Microneedle Array for Minimally Invasive In Vivo Glucose Measurements
To monitor blood glucose level reliably, diabetic patients usually have to undergo frequent fingerstick tests to draw out fresh blood which is painful and inconvenient with potential risk of cross contamination especially when the lancet is reused or not properly steri-lized. This work reports a novel SERS (surface enhanced Raman spectroscopy) sensor for the in situ intradermal detection of glucose based on a low-cost PMMA MN array. After incorporating 1-decanethiol (1-DT) onto the silver-coated array surface, the sensor was calibrated in the range of 0 to 20 mM in skin phantoms then tested for the in vivo quantification of glucose in a mouse model of STZ- induced type Ⅰ diabetes. The results showed that the functional polymethyl methacrylate microneedle (F-PMMA MN) array was able to directly measure glucose in the ISF in a few mins and retain its structural integrity without swelling hydrated. The Clarke error grid analysis of measured data indicated that 93% of the data points lie in zones A and B. Moreover, the MN array exhibited minimal inva-siveness to the skin as the skin recovered well without any noticeable adverse reaction in 10 mins after measurements. With further improvement and proper validation, this polymeric MN array based SERS biosensor has the potential to be used in painless glucose monitoring of diabetic patients in the future.